Published in
Taylor and Francis Group, Journal of Medical Economics (JME), 1(21), p. 38-46, 2017
DOI: 10.1080/13696998.2017.1372222
Links
Tools
The cost-effectiveness and monetary benefits of dabigatran in the prevention of arterial thromboembolism for patients with non-valvular atrial fibrillation in the Netherlands
Journal article published in 2017 by
Marinus van Hulst 
,
Jelena Stevanovic,
Maartje S. Jacobs ,
Robert G. Tieleman,
Bregt Kappelhoff,
Maarten J. Postma
,
Jelena Stevanovic,
Maartje S. Jacobs ,
Robert G. Tieleman,
Bregt Kappelhoff,
Maarten J. Postma
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 